Pharmacokinetics of Hoasca alkaloids in healthy humans

被引:202
作者
Callaway, JC
McKenna, DJ
Grob, CS
Brito, GS
Raymon, LP
Poland, RE
Andrade, EN
Andrade, EO
Mash, DC
机构
[1] Univ Kuopio, Dept Pharmaceut Chem, FIN-70211 Kuopio, Finland
[2] Bot Dimens, Occidental, CA 95465 USA
[3] Univ Calif Los Angeles, Harbor Med Ctr, Dept Psychiat, Torrance, CA 90509 USA
[4] Ctr Estudos Med, BR-05020990 Sao Paulo, Brazil
[5] Forens Toxicol Lab, Dept Pathol, Miami, FL 33177 USA
[6] Univ Amazanas, Sch Med, Dept Internal Med, Manaus, Amazonas, Brazil
[7] Univ Miami, Sch Med, Dept Neurol, Miami, FL 33136 USA
关键词
Ayahuasca; serotonin; psychoactivity; religion; addiction;
D O I
10.1016/S0378-8741(98)00168-8
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
N,N-Dimethyltryptamine (DMT), harmine, harmaline and tetrahydroharmine (THH) are the characteristic alkaloids found in Amazonian sacraments known as hoasca, ayahuasca, and yaje. Such beverages are characterized by the presence of these three harmala alkaloids, where harmine and harmaline reversibly inhibit monoamine oxidase A (MAO-A) while tetrahydroharmine weakly inhibits the uptake of serotonin. Together, both actions increase central and peripheral serotonergic activity while facilitating the psychoactivity of DMF. Though the use of such 'teas' has be known to western science for over 100 years, little is known of their pharmacokinetics. In this study, hoasca was prepared and administered in a ceremonial context. All four alkaloids were measured in the tea and in the plasma of 15 volunteers, subsequent to the ingestion of 2 mi hoasca/kg body weight, using gas (GC) and high pressure liquid chromatographic (HPLC) methods. Pharmacokinetic parameters were calculated and peak times of psychoactivity coincided with high alkaloid concentrations, particularly DMT which had an average T-max of 107.5 +/- 32.5 min. While DMT parameters correlated with those of harmine, THH showed a pharmacokinetic profile relatively independent of harmine's, (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:243 / 256
页数:14
相关论文
共 45 条
[1]  
AIRAKSINEN MM, 1980, ACTA PHARMACOL TOX, V46, P308
[2]   TREMORIGENIC EFFECT AND INHIBITION OF TRYPTAMINE AND SEROTONIN RECEPTOR-BINDING BY BETA-CARBOLINES [J].
AIRAKSINEN, MM ;
LECKLIN, A ;
SAANO, V ;
TUOMISTO, L ;
GYNTHER, J .
PHARMACOLOGY & TOXICOLOGY, 1987, 60 (01) :5-8
[3]   METABOLISM OF THE HALLUCINOGEN N,N-DIMETHYLTRYPTAMINE IN RAT-BRAIN HOMOGENATES [J].
BARKER, SA ;
MONTI, JA ;
CHRISTIAN, ST .
BIOCHEMICAL PHARMACOLOGY, 1980, 29 (07) :1049-1057
[4]   MONOAMINE-OXIDASE INHIBITION IN BRAIN AND LIVER PRODUCED BY BETA-CARBOLINES - STRUCTURE-ACTIVITY-RELATIONSHIPS AND SUBSTRATE-SPECIFICITY [J].
BUCKHOLTZ, NS ;
BOGGAN, WO .
BIOCHEMICAL PHARMACOLOGY, 1977, 26 (21) :1991-1996
[5]  
Callaway J.C., 1993, MAPS NEWSLETTER MULT, V4, P30
[6]   PLATELET SEROTONIN UPTAKE SITES INCREASED IN DRINKERS OF AYAHUASCA [J].
CALLAWAY, JC ;
AIRAKSINEN, MM ;
MCKENNA, DJ ;
BRITO, GS ;
GROB, CS .
PSYCHOPHARMACOLOGY, 1994, 116 (03) :385-387
[7]   Quantitation of N,N-dimethyltryptamine and harmala alkaloids in human plasma after oral dosing with ayahuasca [J].
Callaway, JC ;
Raymon, LP ;
Hearn, WL ;
McKenna, DJ ;
Grob, CS ;
Brito, GS ;
Mash, DC .
JOURNAL OF ANALYTICAL TOXICOLOGY, 1996, 20 (06) :492-497
[8]  
Casale J.F., 1995, MICROGRAM, V28, P296
[9]   DIFFERENTIAL INTERACTIONS OF DIMETHYLTRYPTAMINE (DMT) WITH 5-HT1A AND 5-HT2 RECEPTORS [J].
DELIGANIS, AV ;
PIERCE, PA ;
PEROUTKA, SJ .
BIOCHEMICAL PHARMACOLOGY, 1991, 41 (11) :1739-1744
[10]   Effects of Ayahuasca on the human EEG [J].
Don, NS ;
McDonough, BE ;
Moura, G ;
Warren, CA ;
Kawanishi, K ;
Tomita, H ;
Tachibana, Y ;
Bohlke, M ;
Farnsworth, NR .
PHYTOMEDICINE, 1998, 5 (02) :87-96